Top

Published in:

22-11-2022 | Heart Failure | Letter

Clinical implication of device-based algorithm that optimize atrioventricular delay during cardiac resynchronization therapy

Authors: Naoya Kataoka, Teruhiko Imamura

Published in: Heart and Vessels | Issue 7/2023

Excerpt

Recently, a device-based algorithm (DVA) that adjusts atrioventricular delay (AVD) based on intra-cardiac electrocardiogram has been clinically available. Ikeda and colleagues demonstrated that a long-term repeated adjustment of AVD using DVA improved survival in patients with cardiac resynchronization therapy (CRT) [1]. Several concerns should improve the implication of their findings. …

Ikeda Y, Kato R, Tsutsui K, Mori H, Kawano D, Tanaka S, Nakano S, Senbonmatsu T, Iwanaga S, Muramatsu T, Matsumoto K (2022) Impact of long-term optimizing atrioventricular delay using device-based algorithms on cardiac resynchronization therapy. Heart Vessels. https://doi.org/10.1007/s00380-022-02162-4CrossRefPubMed

Yu CM, Hayes DL (2013) Cardiac resynchronization therapy: state of the art 2013. Eur Heart J 34(19):1396–1403CrossRefPubMed

Kwok CS, Rashid M, Beynon R, Barker D, Patwala A, Morley-Davies A, Satchithananda D, Nolan J, Myint PK, Buchan I, Loke YK, Mamas MA (2016) Prolonged PR interval, first-degree heart block and adverse cardiovascular outcomes: a systematic review and meta-analysis. Heart 102(9):672–680CrossRefPubMed

Morales MA, Startari U, Panchetti L, Rossi A, Piacenti M (2006) Atrioventricular delay optimization by doppler-derived left ventricular dP/dt improves 6-month outcome of resynchronized patients. Pacing Clin Electrophysiol 29(6):564–568CrossRefPubMed

Title: Clinical implication of device-based algorithm that optimize atrioventricular delay during cardiac resynchronization therapy
Authors: Naoya Kataoka
Teruhiko Imamura
Publication date: 22-11-2022
Publisher: Springer Japan
Keywords: Heart Failure
Cardiac Resynchronization Therapy
Cardiac Resynchronization Therapy
Cardiac Resynchronization Therapy
Cardiac Resynchronization Therapy
Published in: Heart and Vessels / Issue 7/2023
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI: https://doi.org/10.1007/s00380-022-02206-9

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Clinical implication of device-based algorithm that optimize atrioventricular delay during cardiac resynchronization therapy

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 7/2023

Relation between laxative use and risk of major bleeding in patients with atrial fibrillation and heart failure

The impact of time-of-day reperfusion on remote ischemic conditioning in ST-elevation myocardial infarction: a RIC-STEMI substudy

Stenting of branch pulmonary artery stenosis in children: initial experience and mid-term follow-up of the pul-stent

Feasibility of concomitant left atrial appendage closure and percutaneous coronary intervention in patients with acute coronary syndrome and atrial fibrillation: a randomized pilot study

Incidence, predictors and vascular sequelae of distal limb ischemia in minimally invasive cardiac surgery with femoral artery cannulation: an observational cohort study

1-year outcomes of patients implanted with the Perceval sutureless valve: the Japanese post-marketing surveillance study

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page